• Home
  • Interpretation of ceritinib clinical trial results and future combination therapy strategies for ALK-rearranged NSCLC.

Interpretation of ceritinib clinical trial results and future combination therapy strategies for ALK-rearranged NSCLC.

Author List
Blakely CM, Riess JW
Publication
Expert review of anticancer therapy
Publication ID (Profile URL)
https://researcherprofiles.org/profile/83422848
Publication Year
2019
PubMed ID
31809604
Publication Title
Blakely CM, Riess JW. Interpretation of ceritinib clinical trial results and future combination therapy strategies for ALK-rearranged NSCLC. Expert Rev Anticancer Ther. 2019 12; 19(12):1061-1075.